🔗 Share this article

An underground economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to contact these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with numerous of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering products of unknown origin.

Several experts stated the demand for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or imprisonment.

Service Response and Content Elimination

Based on TikTok, the service has removed violative material and banned associated keywords and search suggestions. The company stated it was dedicated to maintaining the platform safe and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to nine thousand members marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of users, populated with images of slimming results, positive testimonials and step-by-step guides for mixing or injecting at residence.

Within minutes of entering one community, a seller posted contact information, where the majority of purchases occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.

Item Details and Pricing

Within these groups, posts display black plastic parcels with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors usually sold at £160 for 20mg. When asked how much time a pen should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for Telegram stated it regularly monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering substances they cannot confirm. Even if the science behind this drug is valid, these digital products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has already seen patients harmed by self-injection from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to potentially serious medical dangers”.